Company profile: Axiom Metrics
1.1 - Company Overview
Company description
- Provider of e-clinical, EDC, and data management solutions and services for life science organizations.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Axiom Metrics
Aitia
HQ: United States
Website
- Description: Provider of Causal AI and digital twin-based drug discovery solutions. Offers Gemini Digital Twins—computational disease models that simulate genetic and molecular interactions to identify novel drug targets and patient subpopulations—and Causal AI Drug Discovery leveraging multi-omic data to accelerate development of new therapies for neurodegenerative diseases and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aitia company profile →
Enveda Biosciences
HQ: United States
Website
- Description: Provider of a drug discovery platform using machine learning, metabolomics, robotics, and the MS2Mol AI to index nature’s chemical space and predict structures from mass spectrometry, rapidly identifying small molecules; harnesses nature’s chemical diversity to deliver new medicines for complex diseases, novel modalities (protein degradation, stabilization, covalent inhibition), novel targets, and a pipeline in pain, dermatology, immunology, inflammation, and neuroinflammation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enveda Biosciences company profile →
Integrated Proteomics
HQ: United States
Website
- Description: Provider of a comprehensive proteomic data analysis solution, the Integrated Proteomics Pipeline (IP2), designed to make proteomics data analysis easy and streamlined for universities, research hospitals, pharmaceutical companies, and biological research institutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated Proteomics company profile →
Notocord
HQ: France
Website
- Description: Provider of life sciences software for data acquisition, analysis and reporting in experimental drug research, with solutions for cardiovascular, respiratory and electrophysiology signal analysis in Safety Pharmacology, Toxicology, R&D, academic and preclinical research, including NOTOCORD-hem Evolution.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Notocord company profile →
Apprentice
HQ: United States
Website
- Description: Provider of an agentic AI manufacturing platform and GxP SaaS supporting end-to-end manufacturing processes, connecting distributed teams and sites via a Connected Manufacturing Network, enabling enterprise recipe management, facilitating external manufacturing collaboration with real-time data sharing, and supporting secure tech transfer of master resources to streamline product development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apprentice company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Axiom Metrics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Axiom Metrics
2.2 - Growth funds investing in similar companies to Axiom Metrics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Axiom Metrics
4.2 - Public trading comparable groups for Axiom Metrics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →